BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12135538)

  • 1. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.
    Shapira NA; Lessig MC; Murphy TK; Driscoll DJ; Goodman WK
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):141-5. PubMed ID: 12135538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of topiramate in adults with Prader-Willi syndrome.
    Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
    Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-injurious behavior and serotonin in Prader-Willi syndrome.
    Hellings JA; Warnock JK
    Psychopharmacol Bull; 1994; 30(2):245-50. PubMed ID: 7831463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
    Bonnot O; Cohen D; Thuilleaux D; Consoli A; Cabal S; Tauber M
    Eur J Pediatr; 2016 Jan; 175(1):9-18. PubMed ID: 26584571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study.
    Consoli A; Çabal Berthoumieu S; Raffin M; Thuilleaux D; Poitou C; Coupaye M; Pinto G; Lebbah S; Zahr N; Tauber M; Cohen D; Bonnot O
    Transl Psychiatry; 2019 Nov; 9(1):274. PubMed ID: 31685813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rectal self-mutilation, rectal bleeding and Prader-Willi syndrome].
    Campeotto F; Naudin C; Viot G; Dupont C
    Arch Pediatr; 2001 Oct; 8(10):1075-7. PubMed ID: 11683099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate effectiveness in Prader-Willi syndrome.
    Smathers SA; Wilson JG; Nigro MA
    Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural correlates of self-injurious behavior in Prader-Willi syndrome.
    Klabunde M; Saggar M; Hustyi KM; Hammond JL; Reiss AL; Hall SS
    Hum Brain Mapp; 2015 Oct; 36(10):4135-43. PubMed ID: 26173182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetylcysteine provides limited efficacy as treatment option for skin picking in Prader-Willi syndrome.
    Wieting J; Deest M; Bleich S; Frieling H; Eberlein C
    Am J Med Genet A; 2022 Mar; 188(3):828-835. PubMed ID: 34854203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutical approach of obesity in Prader-Willi Syndrome].
    Carvalho DF; Cercato C; Almeida MQ; Mancini MC; Halpern A
    Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):913-9. PubMed ID: 17934657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychiatric aspects of Prader-Willi syndrome – a review].
    Briegel W
    Z Kinder Jugendpsychiatr Psychother; 2018 May; 46(3):238-246. PubMed ID: 28613110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanfacine Extended Release for the Reduction of Aggression, Attention-Deficit/Hyperactivity Disorder Symptoms, and Self-Injurious Behavior in Prader-Willi Syndrome-A Retrospective Cohort Study.
    Singh D; Wakimoto Y; Filangieri C; Pinkhasov A; Angulo M
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):313-317. PubMed ID: 30724590
    [No Abstract]   [Full Text] [Related]  

  • 13. Rectal Picking Masquerading as Inflammatory Bowel Disease in Prader-Willi Syndrome.
    Salehi P; Lee D; Ambartsumyan L; Sikka N; Scheimann AO
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):59-63. PubMed ID: 29470292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of the topography, severity, potential sources of reinforcement, and treatments utilized for skin picking in Prader-Willi syndrome.
    Hustyi KM; Hammond JL; Rezvani AB; Hall SS
    Res Dev Disabil; 2013 Sep; 34(9):2890-9. PubMed ID: 23810929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
    Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
    Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental functional analysis of severe skin-picking behavior in Prader-Willi syndrome.
    Hall SS; Hustyi KM; Chui C; Hammond JL
    Res Dev Disabil; 2014 Oct; 35(10):2284-92. PubMed ID: 24952370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and psychiatric disorders in Prader-Willi syndrome: a population study in Japan.
    Hiraiwa R; Maegaki Y; Oka A; Ohno K
    Brain Dev; 2007 Oct; 29(9):535-42. PubMed ID: 17314021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of psychiatric conceptions of mental and behavioural disorders in Prader-Willi syndrome.
    Whittington J; Holland A
    Neurosci Biobehav Rev; 2018 Dec; 95():396-405. PubMed ID: 30392879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and fluoxetine in Prader-Willi syndrome.
    Benjamin E; Buot-Smith T
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
    Warnock JK; Kestenbaum T
    Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.